<p>WPMY-1 cells expressing mock, PRA or PRB were transiently transfected with control siRNA or siRNA against PR for 24 hours. Cells were washed twice with PBS buffer and replenished with serum free DMEM medium for 48 hours. CM were collected and incubated with PC-3 (<b>A and C</b>) or C4-2B (<b>B and D</b>) cells for cell migration assays (<b>A and B</b>) and Matrigel invasion assays (<b>C and D</b>) as described in Material and Method section. (<b>E</b>) CM were collected from hCAFs in the presence of vehicle or 10 nM of P4 and then mixed with vehicle, 10 ng/ml of SDF-1 or 10 ng/ml IL-6 and incubated with PC-3 cells in Matrigel invasion assays. One-way ANOVA and paired student's t-test calculate the level of significance set at P<0.05 as *...
<p>MDA-MB231 cells were transfected with control siRNA or PKR siRNA for 48 h. <b>A</b>: Following tr...
<p><b>A</b>: HUVECs stimulated with either recombinant human SCF or conditioned medium from NPCs tra...
<p>A. Cell migration rates of pancreatic cancer cells treated with IL-6 (100 ng/mL) or vehicle only ...
<p>Conditioned media (CM) were collected from parental hCAFs, WPMY-1 or their derived cell lines exp...
<p>WPMY-1 and its derived cell lines expressing mock, PRA or PRB were treated with 0, 10 nM and 100 ...
<p>hCAFs and their derived cells expressing mock, PRA or PRB were treated with vehicle, 1(<b>A</b>) ...
<p>hCAFs and their derived cell lines expressing mock, PRA or PRB were treated with vehicle, 1(<b>A<...
<p>WPMY-1 cells expressing mock, PRA or PRB were transiently transfected with control siRNA or siRNA...
<p>(A) Cells were treated with progesterone or MPA (both 100 nM) for 48 h and cell migration was ass...
<p>(A, B) Cells were transfected with siRNA-PKC-ε and -PKC-δ and then were incubated with 0.50 µM [P...
<p>(A) ML-1 cells were transfected with siRNA-control or indicated siRNA-PTK6s for 48 hours prior to...
<p>IP-10 (50 ng/ml), Mig (100 ng/ml), or SDF-1 (100 ng/ml) was added to the PBMC supernatant. T cell...
<p>(<b>a</b>) The CDK5RAP3 stable knockdown SMMC-7721 cells were transfected with p14<sup>ARF</sup> ...
<p>(A) Increased cell viability was observed in cells over-expressing PRKCZ, as measured by MTT cell...
<p><b>A</b>: MDA-MB231 cells (5x10<sup>4</sup>) were placed into the upper compartments of migration...
<p>MDA-MB231 cells were transfected with control siRNA or PKR siRNA for 48 h. <b>A</b>: Following tr...
<p><b>A</b>: HUVECs stimulated with either recombinant human SCF or conditioned medium from NPCs tra...
<p>A. Cell migration rates of pancreatic cancer cells treated with IL-6 (100 ng/mL) or vehicle only ...
<p>Conditioned media (CM) were collected from parental hCAFs, WPMY-1 or their derived cell lines exp...
<p>WPMY-1 and its derived cell lines expressing mock, PRA or PRB were treated with 0, 10 nM and 100 ...
<p>hCAFs and their derived cells expressing mock, PRA or PRB were treated with vehicle, 1(<b>A</b>) ...
<p>hCAFs and their derived cell lines expressing mock, PRA or PRB were treated with vehicle, 1(<b>A<...
<p>WPMY-1 cells expressing mock, PRA or PRB were transiently transfected with control siRNA or siRNA...
<p>(A) Cells were treated with progesterone or MPA (both 100 nM) for 48 h and cell migration was ass...
<p>(A, B) Cells were transfected with siRNA-PKC-ε and -PKC-δ and then were incubated with 0.50 µM [P...
<p>(A) ML-1 cells were transfected with siRNA-control or indicated siRNA-PTK6s for 48 hours prior to...
<p>IP-10 (50 ng/ml), Mig (100 ng/ml), or SDF-1 (100 ng/ml) was added to the PBMC supernatant. T cell...
<p>(<b>a</b>) The CDK5RAP3 stable knockdown SMMC-7721 cells were transfected with p14<sup>ARF</sup> ...
<p>(A) Increased cell viability was observed in cells over-expressing PRKCZ, as measured by MTT cell...
<p><b>A</b>: MDA-MB231 cells (5x10<sup>4</sup>) were placed into the upper compartments of migration...
<p>MDA-MB231 cells were transfected with control siRNA or PKR siRNA for 48 h. <b>A</b>: Following tr...
<p><b>A</b>: HUVECs stimulated with either recombinant human SCF or conditioned medium from NPCs tra...
<p>A. Cell migration rates of pancreatic cancer cells treated with IL-6 (100 ng/mL) or vehicle only ...